Skip to main content

Epidermal Growth Factor Receptor Expression in Human Malignant Glioma: In Vitro and In Vivo Effects of Application of Monoclonal Antibodies to the Epidermal Growth Factor Receptor

  • Conference paper
Molecular Neuro-oncology and Its Impact on the Clinical Management of Brain Tumors

Abstract

Antibodies against the receptor for epidemal growth factor (EGF-R) have long been expected to turn out to be anticancer agents (Mendelsohn et al. 1988). The overexpression of EGF-R is the most constant pathological cell biological feature of human malignant gliomas of the astrocytic lineage (Bigner et al. 1988; Libermann et al. 1985). Such overexpression may be due to gene amplification of the EGF-R gene on chromosome 7 (Bigner and Vogelstein 1990) but may also be present in the absence of gene amplification due to other mechanisms (Chaffanet et al. 1992). An antibody against the extracellular domain of the EGF-R has been generated several years ago, called MAb 425 (Rodeck et al. 1987) and has been developed into a therapeutic compound (EMD 55900). The effects of this antibody as well as others on cell proliferation have been studied in cell culture and in xenotransplants, with contradicting results (Aboud-Pirak et al. 1988; Bigner et al.1988; Rodeck et al. 1987; Werner et al. 1988). It was thought that the antibody might be effective by inhibiting the autocrine self-stiumulation of tumor cells which is afforded by the concomitant secretion of transforming growth factor-α (TGF-α), a homologue to EGF and overexpression of EGF-R (Di Marco et al. 1989). It has yet to be confirmed that this mechanism contributes substantially to the sustained cell proliferation seen in brain tumors. For this interaction to be at all relevant, it has been shown that certain quantitative requirements need to be met (Di Marco et al. 1989). There is only scant clinical evidence that the expression of EGF-R in gliomas due to gene amplification is associated with worse prognosis (Hurtt et al. 1992), and in cell lines it has been shown that despite the presence of the constituents of the autocrine loop for EGF/TGF-α there is little dependence of the cells on this loop for autostimulation of proliferation (Westphal et al., 1993).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Aboud-Pirak E, Hurwitz E, Pirak ME, Bellot F, Schlessinger J, Sela M (1988) Efficacy of antibodies to epidermal growth factor receptor against KB carcinoma in vitro and in nude mice. J Natl Cancer Inst 80: 1605–1611

    Article  PubMed  CAS  Google Scholar 

  • Bigner SH, Burger PC, Wong AJ, Werner MH, Hamilton SR, Muhlbaier LH, Vogelstein B, Bigner DD (1988) Gene Amplification in malignant human gliomas: clinical and histopathological aspects. J Neuropath Exp Neurol 47: 191–205

    Article  PubMed  CAS  Google Scholar 

  • Bigner SH, Vogelstein B (1990) Cytogenetics and molecular genetics of malignant gliomas and medulloblastoma. Brain Pathol 1: 12–18.

    Article  PubMed  CAS  Google Scholar 

  • Brady LW, Markoe AM, Woo DV, Rackover MA, Koprowski H, Steplewski Z, Peyster RG (1990) Iodine-125 labeled anti-epidermal growth factor receptor-425 in the treatment of malignant astrocytomas. J Neurol Sci 34: 243–249

    CAS  Google Scholar 

  • Chaffanet M, Chauvin C, Laine M, Berger F, Chedin M, Rost N, Nissou MF, Benabid AL (1992) EGF-receptor amplification and expression in human brain tumors. Eur J Cancer 28: 11–17

    Article  PubMed  CAS  Google Scholar 

  • Coussens L, Yang-Feng TL, Liao YC, Chen E, Gray A, McGrath J, Seeburg PH, Liberman TW, Schlessinger J, Francke U, Levinson A, Ullrich A (1985) Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene. Science 230: 1132–1139

    Article  PubMed  CAS  Google Scholar 

  • Di Marco E, Pierce JH, Fleming TP, Kraus MH, Molloy CJ, Aaronson SA, Di Fiore PP (1989) autocrine interaction between TGFa and the EGF-receptor: quantitative requirements for induction of the malignant phenotype. Oncogene 4:831–838

    Google Scholar 

  • Eisenberger MA, Fontana JA (1992) Suramin, an active nonhormonal cytotoxic drug fir treatment of prostate cancer: compelling reasons for testing in patients with hormone-refractory breast cancer. J Natl Cancer inst 84: 3–5

    Article  PubMed  CAS  Google Scholar 

  • Ekstrand AJ, James CD, Canenee WK, Seliger B, Pettersson RF, Collins VP (1991) Genes for epidermal growth factor, transforming growth factor alpha and epidermal growth factor and their expression in human gliomas in vivo. Cancer Res 51: 2164–2172

    PubMed  CAS  Google Scholar 

  • Epenetos AA, Courtenay-Luck N, Pickering D, Hooker G, Durbin H, Lavender JP, McKenzie CG (1985) Antibody guided irradiation of brain glioma by arterial infusion of radioactive monoclonal antibody against epidermal growth factor receptor and blood group A antigen. Br Med J 290: 1463–1466

    Article  CAS  Google Scholar 

  • Erickson CA, Turley EA (1987) The effects of epidermal growth factor on neural crest cells in tissue culture. Exp Cell Res 169: 267–279

    Article  PubMed  CAS  Google Scholar 

  • Hamel W, Westphal M, Shepard HM (1992) Proto-oncogene expression inhuman glioma derived cell lines. Int J Oncol, 1: 673–682

    PubMed  CAS  Google Scholar 

  • Hirota N, Ueda M, Ozawa S, Abe O, Shimizu N (1989) Suppression of an epidermal growth factor receptor hyperproducing tumor by an immunotoxin conjugate of gelonin and a monoclonal antiepidermal growth factor receptor antibody. Cancer Res 49: 7106–7109

    PubMed  CAS  Google Scholar 

  • Hossmann KA, Seo K, Szymas J, Wechsler W (1990) Quantitative analysis of experimental peritumoral edema in cats. Adv Neurol 52: 449–458

    PubMed  CAS  Google Scholar 

  • Hudziak RM, Lewis GD, Winget M, Fendly BM, Shepard HM, Ullrich A (1989) p185her monoclonal antibody has antiproliferative effects in vitro and sensitizes human breast tumor cells to tumor necrosis factor. Mol Cell Biol 9:1165–1172

    Google Scholar 

  • Hurtt MR, Moossy J, Donovan PM, Locker J (1992) Amplification of epidermal growth factor receptor gene in gliomas: histopathology and prognosis. J Neuropath Exp Neurol 51: 84–90

    Article  PubMed  CAS  Google Scholar 

  • Keating MT, Williams LT (1988) Autocrine stimulation of intracellular PDGF receptors in vsis.transformed cells. Science 239: 914–916

    Article  PubMed  CAS  Google Scholar 

  • Libermann TA, Nusbaum HR, Razon N, Kris R, Lax I, Soreq H, Whittle N, Waterfiled MD, Ullrich A, Schlessinger J (1985) Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumors of glial origin. Nature 313: 144–147

    Article  PubMed  CAS  Google Scholar 

  • Lund-Johansen M, Bjerkvig R, Humphrey PA, Bigner SH, Bigner DD, Laerum O-D (1990) Effect of epidermal growth factor on glioma cell growth, migration and invasion in vitro. Cancer Research 50: 6039–6044

    PubMed  CAS  Google Scholar 

  • McVicar DW, Davis DF, Merchant RE (1992) In vitro analysis of the proliferative potential od T cells from patients with brain tumor: glioma-associated immunosuppression unrelated to intrinsic cellular defect. J Neurosurg 76: 251–260

    Article  PubMed  CAS  Google Scholar 

  • Mendelsohn J, Masui H, Sunada H, MacLeod C (1988) Monoclonal antibodies against the receptor for epidermal growth factor as potential anticancer agents. UCLA Symp Mol Biol 56: 307–312

    CAS  Google Scholar 

  • Murthy U, Basu A, Rodeck U, Herlyn M, Ross AH, Das M (1987) Binding of an antagonistic monoclonal antibody to intact and fragmented EGF-receptor polypeptide. Arch Biochem Biophys 252: 549–560

    Article  PubMed  CAS  Google Scholar 

  • Olivier S, Formento P, Fischel JL, Etienne MC, Milano G (1990) Epidermal growth factor receptor expression and suramin cytotoxicity in vitro. Eur J Cancer 26: 876–871

    Article  Google Scholar 

  • Rodeck U, Herlyn M, Herly D, Molthoff C, Atkinson B, Varello M, Steplewski Z, Koprowski H (1987) Tumor growth modulation by a monoclonal antibody to the epidermal growth factor receptor: Immunologically mediated and effector cell-independent effects. Cancer Res 47: 3692–3696

    Google Scholar 

  • Schlegel U, Moots PL, Rosenblum MK, Thaler HT, Furneaux HM (1990) Expression of transforming growth factor alpha in human gliomas. Oncogene 5: 1839–1849

    PubMed  CAS  Google Scholar 

  • Simpson Dl, Morrison R, de Vellis J, Herschman HR (1982) Epidermal growth factor binding and mitogenic activity on purified populations of cells from the cental nervous system. J Neurosci Res 8: 453–462

    Google Scholar 

  • Strommer K, Hamou MF, Diggelmann H, de Tribolet N (1990) Cellular and tumoral heterogeneity of EGF-R gene amplification in human malignant gliomas. Acta Neurochir 107: 82–87

    CAS  Google Scholar 

  • Sutter A. Hekmat A, Luckenbach GA (1991) Antibody-mediated tumor cytotoxicity of microglia. Pathobiol 59: 254–258

    Google Scholar 

  • Torp SH, Helseth E, Dalen A, Unsgaard G (1991) Epidermal growth factor expression in human gliomas. Cancer Immunol Immunother 33: 61–64

    Article  PubMed  CAS  Google Scholar 

  • Werner MH, Humphrey PA, Bigner DD, Bigner SH (1988) Growth effects of epidermal growth factor ( EGF) and a monoclonal antibody against the EGF receptor on four glioma cell lines. Acta Neuropathol 77: 196–201

    Google Scholar 

  • Westermark B, Magnusson A, Heldin CH (1982) Effect of epidermal growth factor on membrane motility and cell locomotion in cultures of human clonal glioma cells. J Neurosci Res 8: 491–507

    Article  PubMed  CAS  Google Scholar 

  • Westphal M, Herrmann HD (1989) Growth factor biology and oncogene activation in human gliomas and their implications for specific therapeutic concepts. Neurosurgery 25: 681–694

    Article  PubMed  CAS  Google Scholar 

  • Westphal M, Ackermann E, Hoppe J, Herrmann HD (1991) Receptors for platelet derived growth factor in human glioma cell lines and influence of suramin on cell proliferation. J Neuro-Oncol 11: 207–213

    Article  CAS  Google Scholar 

  • Westphal M, Nitschke M, Nausch H, Herrmann HD (1993) Cell lines derived from human gliomas activate multiple autocrine pathways simultaneously. Int J Oncol 2: 569–575

    PubMed  CAS  Google Scholar 

  • Zalutzky, MR, Moseley RP, Benjamin JC, Colapinto EV, Fuller GN, Coakham HP, Bigner DD (1990) Monoclonal antibody and a F (ab’) 2 fragment delivery to tumor in patients with glioma: comparison of intracarotid and intravenous administration. Cancer Res 50: 4105–4110

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1994 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Westphal, M. et al. (1994). Epidermal Growth Factor Receptor Expression in Human Malignant Glioma: In Vitro and In Vivo Effects of Application of Monoclonal Antibodies to the Epidermal Growth Factor Receptor. In: Wiestler, O.D., Schlegel, U., Schramm, J. (eds) Molecular Neuro-oncology and Its Impact on the Clinical Management of Brain Tumors. Recent Results in Cancer Research, vol 135. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-85039-4_17

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-85039-4_17

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-85041-7

  • Online ISBN: 978-3-642-85039-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics